Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2019 08:30 ET | Source: Trxade Group Inc.

Trxade Group, Inc. Discusses Seven Consecutive Quarters of Revenue Growth, Provides Operational Progress

NEW YORK, Dec. 12, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Trxade Group, Inc. (OTCQB:TRXD)(“Trxade”) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio...
December 17, 2018 08:30 ET | Source: Progressive Care, Inc.

Uptick Newswire Hosts Progressive Care Inc’s CEO to Discuss an Exciting New Acquisition Prospect and Company Growth

PHOENIX, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast features Progressive Care Inc. (OTCQB: RXMD), (The Company) a personalized healthcare services and technology company....
February 01, 2018 07:30 ET | Source: Progressive Care, Inc.

Progressive Care CEO, S. Parikh Mars Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD) (the “company”), a healthcare services and technology company, today announced, the release of CEO, Shital Mars’...
December 11, 2017 08:00 ET | Source: I-Minerals Inc.

Uptick Newswire “Stock Day” Interviews CEO of I-Minerals on their Domination in the Industrial and Pharmaceutical Industry

Phoenix, AZ, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire, the sole producer of the Uptick Network “Stock Day” Podcast, is keeping investors and shareholders up-to-date on company news and...
December 04, 2017 08:30 ET | Source: Progressive Care, Inc.

Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry

Miami, FL , Dec. 04, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire “Stock Day” host Everett Jolly warmly welcomes back a long awaited guest Shital Mars, CEO of Progressive Care Inc. (OTCPink: RXMD)...
September 26, 2017 10:00 ET | Source: DelMar Pharmaceuticals, Inc.

CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead

VANCOUVER, British Columbia , Sept. 26, 2017 (GLOBE NEWSWIRE) -- Jeffery Bacha, CEO of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) interviews on the Uptick Network Stock Day Podcast with host Everett...